Free Trial

Owens & Minor (NYSE:OMI) Stock Price Down 6% on Analyst Downgrade

Owens & Minor logo with Medical background

Shares of Owens & Minor, Inc. (NYSE:OMI - Get Free Report) traded down 6% on Thursday after UBS Group lowered their price target on the stock from $25.00 to $13.00. UBS Group currently has a buy rating on the stock. Owens & Minor traded as low as $7.69 and last traded at $7.70. 943,408 shares were traded during mid-day trading, a decline of 6% from the average session volume of 1,001,335 shares. The stock had previously closed at $8.19.

Several other equities research analysts have also commented on OMI. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird cut their target price on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 4th. Finally, Citigroup reduced their price target on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $16.79.

Read Our Latest Stock Report on OMI

Insider Transactions at Owens & Minor

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 3.59% of the company's stock.

Hedge Funds Weigh In On Owens & Minor

Several institutional investors have recently modified their holdings of the business. Sterling Capital Management LLC raised its stake in Owens & Minor by 758.3% in the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock valued at $27,000 after purchasing an additional 1,820 shares in the last quarter. Blue Trust Inc. increased its stake in Owens & Minor by 176.8% in the third quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock valued at $44,000 after acquiring an additional 1,780 shares during the last quarter. KBC Group NV lifted its stake in Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company's stock worth $58,000 after purchasing an additional 2,197 shares during the last quarter. Cetera Investment Advisers purchased a new position in shares of Owens & Minor in the 4th quarter worth about $140,000. Finally, Meeder Asset Management Inc. increased its position in shares of Owens & Minor by 844.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company's stock valued at $141,000 after purchasing an additional 8,061 shares during the last quarter. 98.04% of the stock is owned by institutional investors.

Owens & Minor Trading Down 3.8 %

The stock has a fifty day moving average of $12.67 and a two-hundred day moving average of $13.76. The company has a market capitalization of $574.08 million, a PE ratio of -11.45, a PEG ratio of 0.25 and a beta of 0.48. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Further Reading

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines